|
The 2013 MH Scientific Conference happening in Toronto on November 1-2 allows clinicians and scientists to share new data and utilize this information in their current strategies for patient diagnosis and management. The conference also provided motivation for new research efforts, which will not only help progress the field of MH research, but will also contribute to the understanding of muscle dysfunction and disease.
|
|
11/1/2013 to 11/2/2013
|
|
When:
|
11/1/2013
|
|
Where:
|
Chestnut Conference Centre 89 Chestnut St 2nd Floor Toronto, Ontario M5G 1R1 Canada
|
|
Contact:
|
Fay
info@mhaus.org
607-674-7901
|
Online registration is closed.
|
|
« Go to Upcoming Event List
|
|
|
Clinical Significance of Ryanodine Receptor-1 (RYR-1) Gene Variants: New Insights into Pathophysiology, Diagnosis, and Treatment of RYR1-Linked Diseases
Summary/Abstract: Through lectures and interactive discussions with subject matter experts in molecular genetic diagnosis, and muscle function in health and disease, this project will inform physicians and scientists who are researching malignant hyperthermia (MH) and its variants and those who care for patients with MH, heat stroke and muscle breakdown of the latest advances in the field. Sharing this information will advance genetic diagnosis of patients suspected of being at risk for MH, congenital muscle disorders, heat stroke and muscle breakdown with exercise. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of UPSTATE Medical University and MHAUS. UPSTATE Medical University is accredited by the ACCME to provide continuing medical education for physicians.
Educational Credits: Upstate Medical University designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credit(s)TM. Physician should claim only the credit commensurate with the extent of their participation in the activity. #mhsc13
|
|
|